Skip to main content

DRW Securities, LLC

Broker-Dealer

Position in NVO — Novo Nordisk A S

CIK 1481986 CHICAGO, IL

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$317,746
-$721,360 QoQ
Shares Held
6,628
-76.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#872
of 1,348 holders
Holding Since
Sep 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Derivatives in NVO

reported options exposure · as of Sep 30, 2025
CallValue
$0
CallShares
0
PutValue
$510,508
PutShares
9,200

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

DRW Securities, LLC holds $13,449,884 across 5 Drug Manufacturers - General names. NVO ranks #4 (2.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NVO
Novo Nordisk A S
This page
6,628 $317,746

All Filings in NVO

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $317,746 6,628
2026-03-31 $1,039,106 28,275
2025-09-30 $630,532 11,363
2025-09-30 $510,508 9,200
2025-06-30 $3,680,905 53,331
2025-03-31 $9,402,176 135,400
2025-03-31 $9,402,176 135,400
2025-03-31 $361,088 5,200
2024-12-31 $1,548,360 18,000
2024-12-31 $1,548,360 18,000
2024-09-30 $10,292,887 86,444
2024-09-30 $904,932 7,600
2024-09-30 $904,932 7,600
2024-06-30 $1,295,650 9,077
2023-12-31 $202,865 1,961
2023-09-30 $1,382,288 15,200
2023-09-30 $1,318,630 14,500
2023-06-30 $1,727,373 10,674
2023-03-31 $415,355 2,610
2022-12-31 $3,935,416 29,078
2022-06-30 $1,452,044 13,031
2020-09-30 $225,925 3,254